Skip to main content

Table 1 Clinical data for study patients

From: Exploring the association between Morgellons disease and Lyme disease: identification of Borrelia burgdorferi in Morgellons disease patients

Patient # Age Gender Lyme serology Coinfecting tickborne diseases Antibiotic treatment
1 86 Female Positive Babesia microti, Bartonella henselae Treated at time of sampling
2 52 Female Positive Ehrlichia chaffeensis,
Anaplasma phagocytophilum
Previous treatment, but off at time of study
3 56 Female *Positive Not tested Never treated
4 75 Female *Positive Not tested Not treated at time of study
5 50 Male Equivocal Not tested Never treated
6 41 Male Positive Spotted fever group and typhus fever group Began treatment after start of study
7 51 Female *Positive Not tested Never treated
8 53 Female Positive Not tested Previous treatment, but off at time of study
9 35 Female Not tested Not tested Never treated
10 63 Female Positive Spotted fever group and Mycoplasma spp. (Labcorp) Not treated at time of study
11 47 Female *Positive Not tested Not treated at time of study
12 38 Male Positive None On antibiotic therapy during study
13 43 Female Positive Babesia spp. Treated but off antibiotics during study
14 53 Female *Positive Not tested Never treated
15 48 Female Clinical diagnosis, not tested Not tested Not treated at time of study
16 56 Female Not tested Not tested Never treated
17 62 Female *Positive Not tested Not treated at time of study
18 51 Female Not tested Not tested Never treated
19 75 Female **Positive Not tested Had 2 weeks treatment for Lyme but no treatment after
20 60 Female **Positive Not tested Had 3 weeks erythromycin after EM rash and + serology, no treatment after
21 37 Female Positive Not tested Not treated at time of study
22 53 Female Not tested Not tested Not treated at time of study
23 68 Female Not tested Not tested Never treated
24 73 Female Not tested Not tested Never treated
25 58 Female ***Positive Not tested Never treated
  1. All Lyme serology except that of patients 19, 20, and 25 tested and interpreted by IGeneX Reference Laboratories, Palo Alto, CA [10].
  2. *Tested for B. burgdorferi after skin sampling was taken for study.
  3. **Positive by 2-tiered CDC surveillance criteria.
  4. ***Tested by Spectracell Laboratories, Houston, TX.